These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: comparison with transforming growth factor-beta 1. Overall CM. J Cell Physiol; 1995 Jul; 164(1):17-25. PubMed ID: 7790389 [Abstract] [Full Text] [Related]
3. Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts. Di Girolamo N, Lloyd A, McCluskey P, Filipic M, Wakefield D. Am J Pathol; 1997 Feb; 150(2):653-66. PubMed ID: 9033278 [Abstract] [Full Text] [Related]
4. Matrix metalloproteinases and their inhibition in periodontal treatment. Ryan ME, Ramamurthy S, Golub LM. Curr Opin Periodontol; 1996 Feb; 3():85-96. PubMed ID: 8624573 [Abstract] [Full Text] [Related]
5. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y. Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853 [Abstract] [Full Text] [Related]
6. Regulation of gelatinase-A (MMP-2) production by ovine intervertebral disc nucleus pulposus cells grown in alginate bead culture by Transforming Growth Factor-beta(1)and insulin like growth factor-I. Pattison ST, Melrose J, Ghosh P, Taylor TK. Cell Biol Int; 2001 Dec; 25(7):679-89. PubMed ID: 11448107 [Abstract] [Full Text] [Related]
7. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Reynolds JJ. Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940 [Abstract] [Full Text] [Related]
14. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration. Fujiwara M, Muragaki Y, Ooshima A. Br J Dermatol; 2005 Aug; 153(2):295-300. PubMed ID: 16086739 [Abstract] [Full Text] [Related]
15. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs). Dittmann KH, Lottspeich F, Ries C, Petrides PE. Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672 [Abstract] [Full Text] [Related]
16. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR. Oncol Res; 1993 Feb; 5(1):19-28. PubMed ID: 8369572 [Abstract] [Full Text] [Related]